<p>AD = Alzheimer's disease, MCI = Mild Cognitive Impairment, CTL = healthy control, MCI-c = MCI converters and MCI-s = MCI stable. To better compare the performance of the three methods we also calculated the sensitivity (MCI-c predicted as AD) at a fixed specificity (MCI-s predicted as CTL). We set the specificity to that of the visual rating assessment and recalculated the sensitivity and specificity of the other two methods used.</p
A variety of imaging, neuropsychological, and genetic biomarkers have been suggested as potential bi...
A variety of imaging, neuropsychological, and genetic biomarkers have been suggested as potential bi...
Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of majo...
<p>AD = Alzheimer’s disease, MCI = Mild Cognitive Impairment, MCI-c = MCI converter, MCI-nc = MCI no...
PurposeTo compare the accuracies of predicting AD conversion by using a decision support system (Pre...
Purpose: To compare the accuracies of predicting AD conversion by using a decision support system (P...
<p>The accuracy, sensitivity, and specificity for predicting the MCI converters are listed when the ...
<p>Note: Clear non-AD: disease state index <0.17, Probable non-AD: 0.17≤ disease state index <0.33, ...
In Alzheimer’s disease (AD) progression, it is imperative to identify the subjects with mild cogniti...
<p>Sensitivity, specificity, and accuracy (percentage) of classification between AD converters and n...
Mild Cognitive Impairment (MCI) refers to a transitional stage between normal aging and dementia. Th...
In the Alzheimer’s disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) pr...
Alzheimer’s disease (AD) and mild cognitive impairment (MCI) are of great current research interest....
In the Alzheimer's disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) pr...
Visual assessment rating scales for medial temporal lobe (MTL) atrophy have been used by neuroradiol...
A variety of imaging, neuropsychological, and genetic biomarkers have been suggested as potential bi...
A variety of imaging, neuropsychological, and genetic biomarkers have been suggested as potential bi...
Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of majo...
<p>AD = Alzheimer’s disease, MCI = Mild Cognitive Impairment, MCI-c = MCI converter, MCI-nc = MCI no...
PurposeTo compare the accuracies of predicting AD conversion by using a decision support system (Pre...
Purpose: To compare the accuracies of predicting AD conversion by using a decision support system (P...
<p>The accuracy, sensitivity, and specificity for predicting the MCI converters are listed when the ...
<p>Note: Clear non-AD: disease state index <0.17, Probable non-AD: 0.17≤ disease state index <0.33, ...
In Alzheimer’s disease (AD) progression, it is imperative to identify the subjects with mild cogniti...
<p>Sensitivity, specificity, and accuracy (percentage) of classification between AD converters and n...
Mild Cognitive Impairment (MCI) refers to a transitional stage between normal aging and dementia. Th...
In the Alzheimer’s disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) pr...
Alzheimer’s disease (AD) and mild cognitive impairment (MCI) are of great current research interest....
In the Alzheimer's disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) pr...
Visual assessment rating scales for medial temporal lobe (MTL) atrophy have been used by neuroradiol...
A variety of imaging, neuropsychological, and genetic biomarkers have been suggested as potential bi...
A variety of imaging, neuropsychological, and genetic biomarkers have been suggested as potential bi...
Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of majo...